Wanwisa Dejnirattisai
Overview
Explore the profile of Wanwisa Dejnirattisai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
8124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huhn A, Nissley D, Wilson D, Kutuzov M, Donat R, Tan T, et al.
Nat Commun
. 2025 Jan;
16(1):338.
PMID: 39746910
Key functions of antibodies, such as viral neutralisation, depend on high-affinity binding. However, viral neutralisation poorly correlates with antigen affinity for reasons that have been unclear. Here, we use a...
2.
Asor R, Olerinyova A, Burnap S, Kushwah M, Soltermann F, Rudden L, et al.
Proc Natl Acad Sci U S A
. 2024 Sep;
121(40):e2403260121.
PMID: 39298475
Cellular processes are controlled by the thermodynamics of the underlying biomolecular interactions. Frequently, structural investigations use one monomeric binding partner, while ensemble measurements of binding affinities generally yield one affinity...
3.
Thanh T, Tu N, Nguyet L, Thuy C, Thuan N, Ny N, et al.
Int J Infect Dis
. 2024 Aug;
147:107173.
PMID: 39094762
Objectives: We studied the immunogenicity after primary and booster vaccinations of the Abdala COVID-19 vaccine, a receptor-binding domain protein subunit vaccine, in Vietnamese people by determining the level of neutralization...
4.
Nhu L, Chambers M, Chantratita N, Cheah P, Day N, Dejnirattisai W, et al.
Wellcome Open Res
. 2024 Jul;
9:181.
PMID: 39022321
A strong and effective COVID-19 and future pandemic responses rely on global efforts to carry out surveillance of infections and emerging SARS-CoV-2 variants and to act accordingly in real time....
5.
Chansaengpetch S, Kaewlai R, Virojskulchai T, Jaroonpipatkul A, Chierakul N, Muangman N, et al.
Multidiscip Respir Med
. 2024 May;
19.
PMID: 38756043
Background: Little is known about culture-negative subclinical pulmonary tuberculosis (TB), and its diagnosis remains challenging. Therefore, this study aimed to identify the characteristics and the extent of disease associated with...
6.
Muhlemann B, Wilks S, Baracco L, Bekliz M, Carreno J, Corman V, et al.
Sci Transl Med
. 2024 May;
16(747):eadl1722.
PMID: 38748773
The evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires ongoing monitoring to judge the ability of newly arising variants to escape the immune response. A surveillance system necessitates...
7.
Hunt M, Hinrichs A, Anderson D, Karim L, Dearlove B, Knaggs J, et al.
bioRxiv
. 2024 May;
PMID: 38746185
The SARS-CoV-2 genome occupies a unique place in infection biology - it is the most highly sequenced genome on earth (making up over 20% of public sequencing datasets) with fine...
8.
Taechasan N, Scherwitzl I, Supasa P, Dejnirattisai W, Sriruksa K, Limpitikul W, et al.
Virus Res
. 2024 May;
345:199382.
PMID: 38697295
Natural killer cells (NK cells) are the front line of immune cells to combat pathogens and able to influence the subsequent adaptive immune responses. One of the factors contributing to...
9.
Zhou D, Supasa P, Liu C, Dijokaite-Guraliuc A, Duyvesteyn H, Selvaraj M, et al.
Nat Commun
. 2024 Mar;
15(1):2734.
PMID: 38548763
Under pressure from neutralising antibodies induced by vaccination or infection the SARS-CoV-2 spike gene has become a hotspot for evolutionary change, leading to the failure of all mAbs developed for...
10.
Muhlemann B, Wilks S, Baracco L, Bekliz M, Carreno J, Corman V, et al.
bioRxiv
. 2023 Oct;
PMID: 37808679
The antigenic evolution of SARS-CoV-2 requires ongoing monitoring to judge the immune escape of newly arising variants. A surveillance system necessitates an understanding of differences in neutralization titers measured in...